Development of chromatographic methods and their applications for the analysis of chiral drug metabolism by enzymes altered during pregnancy

Sara Korner-Wyss
DOI: https://doi.org/10.3929/ETHZ-A-010361935
Abstract:During pregnancy, the female body undergoes important changes not only anatomically, but also physiologically. These changes can lead to alterations in drug response and drug metabolism or even the emergence of new biological targets. Due to the scarcity of pharmacokinetic and pharmacodynamic data on newer and particularly chiral drugs, mainly ”old drugs” are used during gestation, even though these compounds are not often the first choice treatment. In light of this situation, in vitro methods for the assessment of chiral drug metabolism during pregnancy is of significant interest and importance. With newly developed gas chromatographic (GC) methods for chiral and also non-chiral applications, separation of drug enantiomers and their metabolites were successfully performed. Two model compounds, with poor knowledge of safe use in pregnancy, were selected to establish in vitro methods, methylphenidate (MPH), a commonly used drug for the treatment of the attention deficit hyperactivity disorder (ADHD) in children and adults, and tramadol (TMD), a weak μ-receptor agonist for the treatment of moderate-severe pain. Both compounds are commercially available as racemic mixtures. For a few years, methylphenidate is also approved in enantiomeric form. Because samples with high water content or improper handling of chiral GC columns rapidly lead to column impairment and unreliable results, an option for chiral GC column state and performance check was needed. Since no test mixture for such conditions was available, a new chiral test mixture for cyclodextrin based (CD) stationary phases with versatile applicability was developed. The mixture consists of twelve enantiomer pairs with different functional groups and was tested on 14 chiral CD-columns. Successful analysis was obtained and no co-elution of any compound was observed. Generally best enantiomeric separation was achieved with β-CD capillary columns. Thereof, on one column all enantiomers were separated (BGB-176SE, BGB Analytics). On the column Beta Dex TM 325 (Supelco), besides methylphenidate, every enantiomer pair was separated. On other columns (α-, β-, γ-CD) at least one enantiomer pair was baseline separated (Rs ≥ 1.5). The elution of the enantiomers still occurred in random order. Since different mechanisms are responsible for chiral recognition on cyclodextrins, separation efficiency and elution order are difficult to predict. However, the two enantiomeric forms of γ-valerolactone showed the same elution order on all columns. It is assumed to be the result of a
Chemistry,Medicine
What problem does this paper attempt to address?